Aminoglycoside-Related Nephrotoxicity and Ototoxicity in Clinical Practice: A Review of Pathophysiological Mechanism and Treatment Options
- PMID: 36738370
- DOI: 10.1007/s12325-023-02436-x
Aminoglycoside-Related Nephrotoxicity and Ototoxicity in Clinical Practice: A Review of Pathophysiological Mechanism and Treatment Options
Abstract
Aminoglycosides are a class of medications used to treat certain bacterial infections, specifically gram-negative aerobes. These drugs can be used alone as first-line treatments or in combination with other medications. There can be many different formulations of aminoglycosides including oral, inhalants, intravascular, intramuscular, or intraventricular. There are many distinctive types of aminoglycosides, and although they provide excellent coverage, they can have a wide variety of side effects. The most prevalent side effects of aminoglycosides are nephrotoxicity and ototoxicity. Aminoglycoside-induced nephrotoxicity is concerning because of the effects that abnormal creatinine levels can have on other drugs and the potential for neurotoxicity. Fortunately, changes in renal function are typically reversible. The kidney is affected by the drug's ability to enter the proximal tubule and cause a buildup of phospholipids in the lysosomes, inhibiting their function. Exposure to aminoglycosides in utero can result in permanent ototoxicity. The mechanism of ototoxicity is through the drug's ability to freely pass into hair cells and cause reactive oxygen species to damage the mitochondria, resulting in cell death. There is not a substantial amount of research regarding the prevention and treatment of adverse effects of aminoglycosides. Future research on the mediation or modulation of these pathophysiological processes would expand their usage in modern medicine.
Keywords: Aminoglycosides; Antibiotics; Nephrotoxicity; Ototoxicity.
© 2023. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
Similar articles
-
Extended-interval aminoglycoside administration for children: a meta-analysis.Pediatrics. 2004 Jul;114(1):e111-8. doi: 10.1542/peds.114.1.e111. Pediatrics. 2004. PMID: 15231982
-
Berberine chloride protects cochlear hair cells from aminoglycoside-induced ototoxicity by reducing the accumulation of mitochondrial reactive oxygen species.Free Radic Biol Med. 2023 Aug 1;204:177-183. doi: 10.1016/j.freeradbiomed.2023.04.017. Epub 2023 Apr 28. Free Radic Biol Med. 2023. PMID: 37119862
-
A new aminoglycoside etimicin shows low nephrotoxicity and ototoxicity in zebrafish embryos.J Appl Toxicol. 2021 Jul;41(7):1063-1075. doi: 10.1002/jat.4093. Epub 2020 Oct 22. J Appl Toxicol. 2021. PMID: 33094525
-
Molecular aspects of renal handling of aminoglycosides and strategies for preventing the nephrotoxicity.Drug Metab Pharmacokinet. 2004 Jun;19(3):159-70. doi: 10.2133/dmpk.19.159. Drug Metab Pharmacokinet. 2004. PMID: 15499183 Review.
-
Clinical and pathophysiologic aspects of aminoglycoside nephrotoxicity.Am J Kidney Dis. 1982 Jul;2(1):5-29. doi: 10.1016/s0272-6386(82)80039-5. Am J Kidney Dis. 1982. PMID: 7048901 Review.
Cited by
-
South African adolescents' lived experiences of acquired hearing loss following multidrug-resistant tuberculosis treatment.Front Rehabil Sci. 2024 Feb 26;5:1336346. doi: 10.3389/fresc.2024.1336346. eCollection 2024. Front Rehabil Sci. 2024. PMID: 38469378 Free PMC article.
-
Macrolactin XY, a Macrolactin Antibiotic from Marine-Derived Bacillus subtilis sp. 18.Mar Drugs. 2024 Jul 23;22(8):331. doi: 10.3390/md22080331. Mar Drugs. 2024. PMID: 39195447 Free PMC article.
-
Aminoglycosides: Single- or Multiple-daily Dosing? An Updated Qualitative Systematic Review of Randomized Trials on Toxicity and Efficacy.Curr Mol Med. 2024;24(11):1358-1373. doi: 10.2174/1566524023666230801160452. Curr Mol Med. 2024. PMID: 37533241
-
Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches.Front Microbiol. 2024 Oct 11;15:1487829. doi: 10.3389/fmicb.2024.1487829. eCollection 2024. Front Microbiol. 2024. PMID: 39464394 Free PMC article.
-
Identification of Druggable Binding Sites and Small Molecules as Modulators of TMC1.bioRxiv [Preprint]. 2024 Dec 20:2024.03.05.583611. doi: 10.1101/2024.03.05.583611. bioRxiv. 2024. PMID: 38826329 Free PMC article. Preprint.
References
-
- Van Hoey Pharm NMD. Aminoglycoside antibiotics, Salem Press Encyclopedia of Health. Salem Press; 2023. https://search-ebscohost-com.aucmed.idm.oclc.org/login.aspx? . Accessed 1 Feb 2023.
-
- Beauduy CE, Winston LG. Aminoglycosides & spectinomycin. In: BG Katzung, editor. Basic & clinical pharmacology, 14th ed. New York: McGraw-Hill Education; 2017. . http://accessmedicine.mhmedical.com/content.aspx?aid=1148440182 . Accessed 26 May 2022.
-
- Block M, Blanchard DL. Aminoglycosides. Treasure Island (FL): StatPearls; 2022. http://www.ncbi.nlm.nih.gov/books/NBK541105/ . Accessed 7 Dec 2022.
-
- Stankowicz MS, Ibrahim J, Brown DL. Once-daily aminoglycoside dosing: an update on current literature. Am J Health Syst Pharm. 2015;72(16):1357–64. https://doi.org/10.2146/ajhp140564 . - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical